Innospec Q3 2026 earnings

IOSP · 2026-11-03 16:23 AMC ET · 8-K on SEC · 10-Q on SEC

Revenue up 7% YoY and operating income up 7% YoY, with all businesses contributing to growth and net cash increasing to $251.9 million.

Headline numbers

MetricActualYoYQoQ8-K location
Revenue$473.6M+7%—Ex. 99.1, income statement
EPS (GAAP)$1.29+148%—Ex. 99.1, income statement
EPS (adjusted)$1.29+15%—Ex. 99.1, income statement
Net income$31.8M+147%—Ex. 99.1, income statement
Adj. EBITDA$51.4M+16%—Ex. 99.1, income statement
Adj. EBITDA margin10.9%+1.2 pp—Ex. 99.1, income statement

Revenue breakdown

SegmentActualYoYShare of revenueNote
Performance Chemicals$180.5M+6%38%Operating income +84% YoY; gross margin +3.7 pp YoY
Fuel Specialties$180.7M+5%38%Operating income +1% YoY; gross margin -0.5 pp YoY
Oilfield Services$112.4M+13%24%Operating income +40% YoY; gross margin -1.8 pp YoY

Margins and costs

  • Gross margin 27.3% (prior 27.4%, change -0.1 pp)
  • Operating expenses $87.4M (+21% YoY)
  • One-offs in the quarter Restructuring charge; Impairment of property, plant and equipment; Impairment of intangible assets
  • Effective tax rate 24.7% (prior-year 22.7%, year-to-date 24.7%)
  • Non-GAAP bridge Adds back interest, taxes, depreciation, amortization, FX, legacy costs, contingent consideration, restructuring, and impairments to get from GAAP to adjusted EBITDA and adjusted EPS.

KPIs

MetricActualPrior quarterPrior yearChange
Cash from operations$17.4M$7.2M$39.1M+141% QoQ, -56% YoY
Net cash$251.9M$250.2M$250.2M+0.7% QoQ, +0.7% YoY
Dividend per share$0.94$0.92$0.92+2.2% QoQ, +2.2% YoY

Guidance

not stated in the 8-K

What drove it

  • Revenue story Revenue increased 7% YoY, driven by Performance Chemicals (+6%), Fuel Specialties (+5%), and Oilfield Services (+13%).
  • EPS story Adjusted EPS increased 15% YoY, driven by higher operating income and margins across all segments.
  • One-off check Restructuring charge, impairment of property, plant and equipment, and impairment of intangible assets totaling $41.9M (non-recurring).

The good

  • Adjusted EBITDA margin expanded 1.2 pp YoY
  • All three segments delivered operating income growth YoY
  • Net cash increased to $251.9M

The bad

  • Cash from operations decreased 56% YoY to $17.4M
  • Oilfield Services gross margin decreased 1.8 pp YoY
  • Performance Chemicals volume decreased 5% YoY

The ugly

  • none

Open questions

  • What specific factors caused the significant decline in operating cash flow YoY?
  • What is the timeline and expected impact of the plant efficiency upgrades in North Carolina?
  • When will the legacy Middle East business activity delays and elevated raw material costs be resolved?
Full release

Innospec (IOSP) earnings release, November 3, 2026

Innospec Inc. (IOSP) · Form 8-K, Item 2.02 · Filed · SEC filing

Innospec REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS

All businesses contributed to revenue and operating income growth

Continued strength in Fuel Specialties; Double-digit operating income growth in Performance Chemicals and Oilfield Services

Cash flow of $17.4 million generated from operations; Net cash improved to $251.9 million

GAAP EPS $1.29 and adjusted non-GAAP EPS $1.29

Semi-annual dividend of 94 cents; Annual dividend increased by 9 percent

Englewood, CO – November 3, 2026 – Innospec Inc. (NASDAQ: IOSP) today announced its financial results for the third quarter ended September 30, 2026 and declared a semi-annual dividend of 94 cents per common share for the second half of 2026, which will be paid on November 25, 2026 to shareholders of record as of November 17, 2026. This brings the annual dividend to $1.86 per share, a 9 percent increase over 2025.

Total revenues for the third quarter were $473.6 million, an increase of 7 percent from $441.9 million in the corresponding period last year. Net income attributable to Innospec for the quarter was $31.8 million or $1.29 per diluted share, compared to $12.9 million or 52 cents per diluted share recorded last year.

Adjusted EBITDA for the quarter was $51.4 million compared to $44.2 million reported in the same period a year ago. Innospec generated cash from operating activities of $17.4 million, before capital expenditures of $15.6 million in the quarter. The quarter closed with net cash of $251.9 million.

Results for this quarter include some special items, which are summarized in the table below. Excluding these items, adjusted non-GAAP EPS in the third quarter was $1.29 per diluted share, compared to $1.12 per diluted share a year ago.

Adjusted EBITDA and net income attributable to Innospec excluding special items and related per-share amounts together with net cash, are non-GAAP financial measures that are defined and reconciled with GAAP results herein and in the schedules below.

Commenting on the third quarter results, Patrick S. Williams, President and Chief Executive Officer, said,

“This was another good quarter for Innospec with all businesses contributing to solid revenue and strong operating income growth.

Performance Chemicals sales growth and margin improvement drove an 84 percent operating income increase over last year. In North Carolina, we expect to commission our recent plant efficiency upgrades by year-end. These upgrades are expected to increase capacity, productivity and yields on a wide range of personal care and other products. As utilization of this new capacity improves and progress on new products continues, we expect further growth and margin improvement in the coming quarters.

Fuel Specialties had another strong quarter delivering revenue growth and steady operating income with margins that remained within our target range. As expected, the business has continued to deliver consistent results.

Oilfield Services operating income grew 40 percent and operating margins improved, driven by our recent DRA plant expansion. While sequential results were lower than expected on continued activity delays in our legacy Middle East business and elevated raw material costs, we are expecting improvement across several of these areas to drive sequential operating income growth in the fourth quarter.”

Revenues in Performance Chemicals of $180.5 million were up 6 percent from $170.8 million in the third quarter of last year. Volume reductions of 5 percent and a negative currency impact of 1 percent were offset by a positive price and product mix of 12 percent. Gross margins of 18.8 percent increased by 3.7 percentage points from the same quarter last year. Operating income of $16.9 million increased 84 percent from $9.2 million in the prior year period.

Revenues in Fuel Specialties of $180.7 million were up 5 percent from $172.0 million in the third quarter of last year. Volumes were up 3 percent and the price and product mix up 2 percent. Gross margins of 35.1 percent decreased by 0.5 percentage points over last year. Operating income of $35.6 million was up 1 percent from $35.3 million a year ago.

Revenues in Oilfield Services of $112.4 million for the quarter were up 13 percent from $99.1 million in the third quarter of last year. Gross margins of 28.2 percent decreased by 1.8 percentage points from the same quarter last year on a weaker sales mix. Operating income of $6.7 million increased 40 percent from $4.8 million in the prior year period.

Corporate costs for the quarter were $18.6 million, compared with $18.2 million a year ago. The adjusted effective tax rate for the quarter was 24.7 percent compared to 22.7 percent in the same period last year, due to the geographical mix of taxable profits.

For the quarter, cash provided by operating activities was $17.4 million compared to $39.1 million a year ago. As of September 30, 2026, Innospec had $251.9 million in cash and cash equivalents and no debt.

Mr. Williams concluded,

“Again this quarter Innospec delivered solid sales and strong operating income growth with higher margins. We remain focused on significant opportunities for continued growth and margin improvement across all our businesses and in particular Performance Chemicals and Oilfield Services.

Operating cash generation was positive in the quarter, and our net cash position remained at over $250 million. We continue to focus on driving increased operating cash flow in the coming quarters with better working capital efficiency. We have significant balance sheet flexibility for organic investment, M&A, dividend growth, and buybacks. This quarter our Board approved a further increase in our semi-annual dividend to 94 cents per share resulting in an annual dividend increase of 9 percent.”

Use of Non-GAAP Financial Measures... (truncated)or presented in accordance with Generally Accepted Accounting Principles in the United States (GAAP). These non-GAAP financial measures comprise adjusted EBITDA, net income attributable to Innospec excluding special items and related per share amounts together with net cash. Adjusted EBITDA is net income attributable to Innospec per our consolidated financial statements adjusted for the exclusion of interest income, net, income taxes, depreciation and amortization, foreign currency exchange (gains)/losses, legacy costs of closed operations, adjustment to fair value of contingent consideration, restructuring charge, impairment of property, plant and equipment and impairment of intangible assets. Net income attributable to Innospec and diluted EPS, excluding special items, per our consolidated financial statements are adjusted for the exclusion of adjustment to fair value of contingent consideration, amortization of acquired intangible assets, legacy costs of closed operations, foreign currency exchange gains, impairment of property, plant and equipment, impairment of intangible assets and restructuring charge. Net cash is cash and cash equivalents less total debt. Reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures are provided herein and in the schedules below.

The Company believes that such non-GAAP financial measures provide useful information to investors and may assist them in evaluating the Company’s underlying performance and identifying operating trends. In addition, these non-GAAP measures address questions the Company routinely receives from analysts and investors and the Company has determined that it is appropriate to make this data available to all investors. While the Company believes that such measures are useful in evaluating the Company’s performance, investors should not consider them to be a substitute for financial measures prepared in accordance with GAAP. In addition, these non-GAAP financial measures may differ from similarly titled non-GAAP financial measures used by other companies and do not provide a comparable view of the Company’s performance relative to other companies in similar industries. Management uses adjusted EPS (the most directly comparable GAAP financial measure for which is GAAP EPS) and net income attributable to Innospec excluding special items and adjusted EBITDA (the most directly comparable GAAP financial measure for which is GAAP net income attributable to Innospec) to allocate resources and evaluate the performance of the Company’s operations and has provided a reconciliation of adjusted EBITDA and net income attributable to Innospec excluding special items, and related per share amounts, to GAAP net income attributable to Innospec herein and in the schedules below.

About Innospec Inc.

Innospec Inc. is an international specialty chemicals company with approximately 2,450 employees in 22 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, Europe, the Middle East, Africa and Asia-Pacific. The Performance Chemicals business creates innovative technology-based solutions for our customers in the Personal Care, Home Care, Agrochemical, Mining and Industrial markets. The Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Oilfield Services provides specialty chemicals to all elements of the oil and gas exploration and production industry.

Financial statements

Income Statement

Three Months Ended September 30 — Schedule 1 (in millions, except share and per share data)

Three Months Ended September 30 – 2026Three Months Ended September 30 – 2025Nine Months Ended September 30 – 2026Nine Months Ended September 30 – 2025
Net sales473.6441.91,418.21,322.4
Cost of goods sold-344.5-325.2-1,027.3-957.4
Gross profit129.1116.7390.9365
Operating expenses:
Selling, general and administrative-71.7-71.9-234.5-215.8
Research and development-16.8-13.7-44.2-40
Adjustment to fair value of contingent consideration1.117.75.716.2
Restructuring charge-0.9-0.9
Impairment of property, plant and equipment-22.9-22.9
Impairment of intangible assets-19.1-19.1
Profit on disposal of property, plant and equipment0.2
Total operating expenses-87.4-110.8-273-282.3
Operating income41.75.9117.982.7
Other income/(expense), net0.53.24.2-1.2
Interest income, net0.42.227.3
Income before income taxes42.611.3124.188.8
Income taxes-111.4-30.5-18.6
Net income31.612.793.670.2
Net loss/(income) attributable to non-controlling interests0.20.2-0.6-1
Net income attributable to Innospec31.812.99369.2
Earnings per share:
Basic1.290.523.772.78
Diluted1.290.523.752.76
Weighted average shares outstanding (in thousands):
Basic24,63124,83424,68424,914
Diluted24,74324,90924,80225,045

Income Statement

SEGMENTAL ANALYSIS OF RESULTS — Schedule 2A (in millions)

Three Months Ended September 30 – 2026Three Months Ended September 30 – 2025Nine Months Ended September 30 – 2026Nine Months Ended September 30 – 2025
Net sales:
Performance Chemicals180.5170.8540.2513
Fuel Specialties180.7172548507.4
Oilfield Services112.499.1330302
473.6441.91,418.21,322.4
Gross profit:
Performance Chemicals3425.895.491.6
Fuel Specialties63.461.2195.7184.9
Oilfield Services31.729.799.888.5
129.1116.7390.9365
Operating income:
Performance Chemicals16.99.24443.3
Fuel Specialties35.635.3109.7107.6
Oilfield Services6.74.82115.1
Corporate costs-18.6-18.2-62.5-56.8
40.631.1112.2109.2
Adjustment to fair value of contingent consideration1.117.75.716.2
Restructuring charge-0.9-0.9
Impairment of property, plant and equipment-22.9-22.9
Impairment of intangible assets-19.1-19.1
Profit on disposal of property, plant and equipment0.2
Total operating income41.75.9117.982.7

Balance Sheet

September 30, 2026 — CONDENSED CONSOLIDATED BALANCE SHEETS (in millions)

September 30, 2026December 31, 2025
Current assets:
Cash and cash equivalents251.9292.5
Trade and other accounts receivable395.6342.3
Inventories361.8329.3
Prepaid expenses1020.1
Prepaid income taxes2.713.1
Other current assets12.47.3
Total current assets1,034.41,004.6
Net property, plant and equipment300.2286.1
Operating lease right-of-use assets47.352.7
Goodwill397.4399
Other intangible assets62.567.7
Deferred tax assets13.513.6
Other non-current assets1.38.7
Total assets1,856.61,832.4
Current liabilities:
Accounts payable164.4174.7
Accrued liabilities157.5152.3
Current portion of operating lease liabilities13.515.9
Current portion of plant closure provisions4.94.9
Current portion of acquisition-related contingent consideration2.57
Accrued income taxes8.45.3
Total current liabilities351.2360.1
Operating lease liabilities, net of current portion33.836.8
Plant closure provisions, net of current portion58.860.2
Deferred tax liabilities15.819.1
Pension liabilities and post-employment benefits12.513.2
Acquisition-related contingent consideration, net of current portion0.51.3
Other non-current liabilities3.78.8
Equity1,380.31,332.9
Total liabilities and equity1,856.61,832.4

Cash Flow

Nine Months Ended September 30 — CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in millions)

Nine Months Ended September 30 – 2026Nine Months Ended September 30 – 2025
Cash Flows from Operating Activities
Net income93.670.2
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization29.534.2

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included or incorporated herein may constitute forward-looking statements. Such forward-looking statements include statements (covered by words like “expects,” “estimates,” “anticipates,” “may,” “could,” “believes,” “feels,” “plans,” “intends,” “outlook” or similar words or expressions, for example) which relate to earnings, growth potential, operating performance, events or developments that we expect or anticipate will or may occur in the future. Although forward-looking statements are believed by management to be reasonable when made, they are subject to certain risks, uncertainties and assumptions, and our actual performance or results may differ materially from these forward-looking statements. Additional information regarding risks, uncertainties and assumptions relating to Innospec and affecting our business operations and prospects are described in Innospec’s Annual Report on Form 10-K for the year ended December 31, 2025, Innospec’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 and other reports filed with the U.S. Securities and Exchange Commission. You are urged to review our discussion of risks and uncertainties that could cause actual results to differ from forward-looking statements under the heading "Risk Factors” in such reports. Innospec undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts:

Corbin Barnes

Innospec Inc.

+44-151-355-3611 corbin.barnes@innospecinc.com

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Innospec earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.